Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview

about

Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview

Item

http://www.wikidata.org/entity/Q58693435

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 08 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Immunological and hematological effects of IL-5

@nl

Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview

@en

type

Item

label

Immunological and hematological effects of IL-5

@nl

Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview

@en

prefLabel

Immunological and hematological effects of IL-5

@nl

Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview

@en

P1476

Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview

@en

P2093

L Koenderman

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils

Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential

Innate lymphoid cells in allergic and nonallergic inflammation

Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis

Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit

Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge

Interleukin-5, eosinophils, and disease

Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation

Interleukin-5 and IL-5 receptor in health and diseases

P304

1979-1988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.13451

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leo Koenderman

M Hassani

P577

2018-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29611207

http://www.w3.org/2001/XMLSchema#string

P921

P932

6220846

http://www.w3.org/2001/XMLSchema#string